GFAP and brain injury: However, these data are consistent with our observation (Figure 5) and the report of Maas and colleagues [3] that diffuse brain injury patients (having relatively higher values of UCH-L1 vs GFAP in our study) had higher mortality rates at discharge and six months than patients with mass lesion (Marshall score V to VI).